98%
921
2 minutes
20
This study aimed to determine the mechanical stresses experienced by third-generation, balloon-expandable transcatheter aortic valves in the presence of aortic calcification, defined by an elevated Agatston score index for calcium. The device under investigation was the Edwards SAPIEN 3 valve (referred to as S3-TAV henceforth), a 26-mm commercial device. Five steps were undertaken. The first was the reconstruction of the three-dimensional (3D) computer-aided design (CAD) model of the device. The second was a simulation of the crimping and reopening process. The third was evaluating the crimping effect on leaflet stress and a comparison to an ideal condition. The fourth was a simulation of real clinical cases. Finally, the subsequent phase of the study entails the post-processing of the simulation results and a comparison with the follow-up data. A high-resolution micro-computed tomography scan was used to develop an accurate 3D geometric mesh of the stent and the valve. The material properties of the leaflets were derived from surgical bioprostheses; the material properties of the stents were based on those of cobalt-chromium. A series of simulations were conducted to assess the impact of systemic pressure loading on the structure. Stress was quantified through the application of finite element analyses. A stress analysis of the valve, conducted using exact geometry derived from high-resolution scans, revealed that peak stresses during the crimping phase were concentrated at the commissural tips, where the leaflets were attached. These regions were identified as the most likely sites for thrombosis and degeneration. The persistence of bulky calcifications following the device expansion results in the formation of paravalvular leakages (PVLs), which act as precursors to thrombosis and structural valve degeneration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3791/67455 | DOI Listing |
J Vis Exp
July 2025
Department of Cardiothoracic Surgery, University of Cincinnati College of Medicine; Department of Cardiothoracic Surgery, Mayo Clinic, Rochester.
This study aimed to determine the mechanical stresses experienced by third-generation, balloon-expandable transcatheter aortic valves in the presence of aortic calcification, defined by an elevated Agatston score index for calcium. The device under investigation was the Edwards SAPIEN 3 valve (referred to as S3-TAV henceforth), a 26-mm commercial device. Five steps were undertaken.
View Article and Find Full Text PDFJ Clin Med
April 2025
Groupe Cardio-Vasculaire Interventionnel, Clinique Pasteur, 45, Avenue de Lombez, 31000 Toulouse, France.
Bicuspid aortic valve (BAV) is the most common congenital heart disease, affecting 0.5-2% of the population and often leading to early aortic valve degeneration. While surgical aortic valve replacement (SAVR) remains the gold standard for treating severe bicuspid aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is emerging as a viable alternative in selected BAV anatomies.
View Article and Find Full Text PDFJ Soc Cardiovasc Angiogr Interv
July 2024
Harvard Medical School, Boston, Massachusetts.
Background: The choice of transcatheter aortic valve replacement (TAVR) prosthesis is crucial in optimizing short- and long-term outcomes. The objective of this study was to conduct a meta-analysis comparing outcomes of third-generation balloon-expandable valves (BEV) vs self-expanding valves (SEV).
Methods: Electronic databases were searched from inception to June 2023 for studies comparing third-generation BEV vs SEV.
JACC Cardiovasc Interv
June 2024
Division of Cardiology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA. Electronic address:
JACC Cardiovasc Interv
April 2024
Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA.